Healthcare provider profile · identity verified

Gordon L Smith, MD

Internal Medicine · ST GEORGE, UT · NPI 1255354718

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	801	236
Levothyroxine Sodium	Levothyroxine Sodium	346	96
Lisinopril	Lisinopril	340	97
Rosuvastatin Calcium	Rosuvastatin Calcium	319	96
Omeprazole	Omeprazole	288	87
Amlodipine Besylate	Amlodipine Besylate	261	85
Alendronate Sodium	Alendronate Sodium	225	74
Tamsulosin Hcl	Tamsulosin Hcl	206	64
Metformin Hcl	Metformin Hcl	183	57
Losartan Potassium	Losartan Potassium	179	60
Metoprolol Succinate	Metoprolol Succinate	177	58
Gabapentin	Gabapentin	168	61
Eliquis	Apixaban	151	38
Pantoprazole Sodium	Pantoprazole Sodium	142	46
Fluoxetine Hcl	Fluoxetine Hcl	141	39
Allopurinol	Allopurinol	139	42
Hydrochlorothiazide	Hydrochlorothiazide	119	37
Furosemide	Furosemide	117	40
Finasteride	Finasteride	111	33
Potassium Chloride	Potassium Chloride	104	37
Simvastatin	Simvastatin	95	28
Spironolactone	Spironolactone	91	29
Chlorthalidone	Chlorthalidone	87	28
Metoprolol Tartrate	Metoprolol Tartrate	84	23
Carvedilol	Carvedilol	82	22
Irbesartan	Irbesartan	81	24
Pravastatin Sodium	Pravastatin Sodium	78	26
Ozempic	Semaglutide	75	16
Tramadol Hcl	Tramadol Hcl	73	16
Citalopram Hbr	Citalopram Hydrobromide	65	21
Clopidogrel	Clopidogrel Bisulfate	61	20
Albuterol Sulfate Hfa	Albuterol Sulfate	60	24
Sertraline Hcl	Sertraline Hcl	60	21
Famotidine	Famotidine	56	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	22
Jardiance	Empagliflozin	55	12
Farxiga	Dapagliflozin Propanediol	47	suppressed
Montelukast Sodium	Montelukast Sodium	47	16
Donepezil Hcl	Donepezil Hcl	46	17
Trazodone Hcl	Trazodone Hcl	46	19
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	15
Doxazosin Mesylate	Doxazosin Mesylate	42	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	14
Oxybutynin Chloride Er	Oxybutynin Chloride	40	13
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Lamotrigine	Lamotrigine	37	suppressed
Ipratropium Bromide	Ipratropium Bromide	36	13
Meloxicam	Meloxicam	36	12
Prednisone	Prednisone	36	28
Fluticasone Propionate	Fluticasone Propionate	34	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Primidone	Primidone	30	suppressed
Atenolol	Atenolol	29	suppressed
Celecoxib	Celecoxib	29	12
Ezetimibe	Ezetimibe	29	11
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	12
Metformin Hcl Er	Metformin Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Fentanyl	Fentanyl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Estradiol	Estradiol	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Cefdinir	Cefdinir	19	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Valsartan	Valsartan	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Baclofen	Baclofen	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	16
Enalapril Maleate	Enalapril Maleate	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Alprazolam	Alprazolam	15	11
Clonazepam	Clonazepam	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Torsemide	Torsemide	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Propranolol Hcl	Propranolol Hcl	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nadolol	Nadolol	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Linzess	Linaclotide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Naproxen	Naproxen	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Veozah	Fezolinetant	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error